Risk-Targeted Behavioral Activation: a Novel Approach to the Management of Treatment-Resistant Depression.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- McGill University
- Enrollment
- 118
- Locations
- 1
- Primary Endpoint
- Depression symptom severity.
Study Overview
Brief Summary
Depression is the leading cause of disability worldwide. Major Depressive Disorder (MDD) is the most common diagnosis made for individuals seeking treatment for depression. Although a wide range of treatments have been developed for the treatment of MDD, a significant proportion of patients fail to respond. This study examined the effectiveness of a 10-week behavioural activation intervention for individuals with treatment-resistant depression.
Detailed Description
Objective
The purpose of the present study was to examine the acceptability and impact of a standardized 10-week risk-targeted behavioral activation (RTBA) intervention as an augmentation strategy in the clinical management of treatment-resistant depression (TRD). Methods: The study sample consisted of 118 individuals with TRD, who were currently absent from work and referred to an occupational rehabilitation service. The RTBA intervention was a 10-week standardized program consisting of weekly visits with a trained clinician. The objectives of treatment included symptom reduction, resumption of important life activities (including return to work) and improvement in quality of life. Measures of depression, perceived injustice, and catastrophic thinking were completed pre-, mid- and post-treatment.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •A diagnosis of Major Depressive Disorder
- •The date of diagnosis of MDD preceded referral by at least 12 months
- •At least one previous prescription of an antidepressant failed to yield therapeutic response
- •Currently taking an antidepressant
- •A PHQ9 score in the moderate to severe range of depression at the time of enrolment
Exclusion Criteria
- •Participating in another psychotherapeutic intervention.
Arms & Interventions
Behavioural Activation for Depression.
All participants were enrolled in a 10-week standardized risk-targeted behavioural activation intervention.
Intervention: Behavioural Activation (Behavioral)
Outcomes
Primary Outcomes
Depression symptom severity.
Time Frame: baseline/immediately after the intervention
The Patient Health Questionnaire (PHQ9) was used to assess depressive symptom severity. PHQ-9 scores can range from 0 to 27 with higher scores indicating more severe depressive symptoms.
Secondary Outcomes
- Catastrophic thinking(baseline/immediately after the intervention.)
- Perceived Injustice(baseline/immediately after the intervention.)
Investigators
Michael Sullivan
Principal investigator
McGill University